Zobrazeno 1 - 10
of 422
pro vyhledávání: '"Garry L. Jennings"'
Autor:
Danielle L. Michell, Waled A. Shihata, Karen L. Andrews, Nurul Aisha Zainal Abidin, Ann-Maree Jefferis, Amanda K. Sampson, Natalie G. Lumsden, Olivier Huet, Marie-Odile Parat, Garry L. Jennings, Robert G. Parton, Kevin J. Woollard, David M. Kaye, Jaye P. F. Chin-Dusting, Andrew J. Murphy
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract The aetiology and progression of hypertension involves various endogenous systems, such as the renin angiotensin system, the sympathetic nervous system, and endothelial dysfunction. Recent data suggest that vascular inflammation may also pla
Externí odkaz:
https://doaj.org/article/89d56ef6af8740c7a60458ad31b61cc1
Publikováno v:
Preventive Medicine Reports, Vol 8, Iss , Pp 204-209 (2017)
This research aimed to determine Australian adults' perceptions of risk factors for heart disease, self-reported behaviours relating to modifiable risk factors, and knowledge of leading causes of death. This study reports on HeartWatch survey data co
Externí odkaz:
https://doaj.org/article/845caa97054d483db102dcb7383cc4e1
Autor:
Peter J. Meikle, Melissa F. Formosa, Natalie A. Mellett, Kaushala S. Jayawardana, Corey Giles, David A. Bertovic, Garry L. Jennings, Wayne Childs, Medini Reddy, Andrew L. Carey, Arul Baradi, Shane Nanayakkara, Andrew M. Wilson, Stephen J. Duffy, Bronwyn A. Kingwell
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 11 (2019)
Background Although acute coronary syndromes (ACS) are a major cause of morbidity and mortality, relationships with biologically active lipid species potentially associated with plaque disruption/erosion in the context of their lipoprotein carriers a
Externí odkaz:
https://doaj.org/article/9fa4b1402627495880c18c3f783b6304
Publikováno v:
Health Research Policy and Systems. 21
Background Releasing timely and relevant clinical guidelines is challenging for organizations globally. Priority-setting is crucial, as guideline development is resource-intensive. Our aim, as a national organization responsible for developing cardio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7f46cfd93f47623844d4402275ece5a
https://doi.org/10.1186/s12961-022-00953-9
https://doi.org/10.1186/s12961-022-00953-9
Autor:
Danielle Esler, Garry L. Jennings, Murray D. Esler, Elisabeth Lambert, Marlies Alvarenga, Jane M. Thompson, Gavin W. Lambert, Markus P. Schlaich, Nina Eikelis, Ling Guo, David M. Kaye
Publikováno v:
Journal of Hypertension. 39:819-829
Unlike noradrenaline, the sympathetic neurotransmitter which overflows to the circulation, adrenaline (ADR) is a secreted hormone, with a low plasma concentration, and plasma concentration for biological action a log order lower than that of noradren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15782485e3faf3cc72de073d068e2c2
https://doi.org/10.1097/hjh.0000000000002748
https://doi.org/10.1097/hjh.0000000000002748
Autor:
Sandra J. Taler, John S. Floras, Alan C. Cameron, Atul R. Chugh, Ninian N. Lang, Daniel Batlle, Christian Delles, Michael Bursztyn, Garry L. Jennings, Anna F. Dominiczak, Rhian M. Touyz
Publikováno v:
Hypertension. 74:1216-1225
No abstract available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802500e9efa1e1302a6d4844fcd91ae1
https://doi.org/10.1161/hypertensionaha.119.13343
https://doi.org/10.1161/hypertensionaha.119.13343
Publikováno v:
Heart, Lung and Circulation. 28:1154-1160
Background This research estimates the broader socioeconomic impacts of reducing pre-hospital delay times across Australia in patients with heart attack symptoms. Methods A cost benefit analysis (CBA) was undertaken to demonstrate the costs and benef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7110b8623c5f937c8d6443bdaa24ba4f
https://doi.org/10.1016/j.hlc.2018.07.018
https://doi.org/10.1016/j.hlc.2018.07.018
Autor:
Michele Battistel, Giulio Barbiero, Garry L. Jennings, Gian Paolo Rossi, Daan J.L. van Twist, Giuseppe Maiolino, Peter W. de Leeuw
Publikováno v:
Hypertension, 73(5), 920-925. LIPPINCOTT WILLIAMS & WILKINS
In summary, long-term exposure to a large, iatrogenic highflow fistula caused very severe systolic hypertension to develop, which was resistant to standard treatment. Closure of the fistula with percutaneous embolization resulted into a marked improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75612bd92eba59bc44011683b1171347
https://doi.org/10.1161/hypertensionaha.118.12068
https://doi.org/10.1161/hypertensionaha.118.12068
Publikováno v:
Heart, Lung and Circulation. 28:198-203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6ad3b69b03dc49945375c98af3f4670
https://doi.org/10.1016/j.hlc.2018.12.002
https://doi.org/10.1016/j.hlc.2018.12.002
Autor:
Lindon M H Wing, Graham J. Macdonald, John Marley, Trefor Morgan, Enayet K. Chowdhury, John J McNeil, Jenny Doust, C. I. Johnston, Malcolm J. West, Philip Ryan, Garry L. Jennings, Monique Breslin, Lawrence J. Beilin, Mark Nelson, Christopher M. Reid, Chau L. B. Ho
Publikováno v:
Journal of Clinical Lipidology. 13:148-155
Background There is currently insufficient evidence to support the use of lipid-lowering drug treatment (LLT) for primary prevention of cardiovascular disease (CVD) in the elderly. Objectives We examined the relationship of early initiation of LLT wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e6e88f69172e7d5d413abfb699486c
https://doi.org/10.1016/j.jacl.2018.08.014
https://doi.org/10.1016/j.jacl.2018.08.014